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Introduction and Review of  the Literature
Arthritis is the leading cause of  disability in the US workforce, 
leading to debilitating limitations with mobility and function in an 
otherwise healthy adult. In 2005, 21.6% of  US adults (46.4 million) 
were formally diagnosed with arthritis, and by 2030 is projected to 
reach 40% (~67 million) [1-3]. A high correlation exists between 
age and the presence of  rotator cuff  disease and glenohumeral 
arthritis. The average age of  individuals with unilateral cuff  tears 
is 58.7, 67.8 years for those with bilateral, and 50% likelihood 
of  a bilateral tear after age 60. It is estimated 13% of  patients in 
their fifties suffer from a cuff  tears and 54% of  patients 60 years 
or older, with more than half  of  asymptomatic rotator cuff  tears 
progressing in size and becoming symptomatic within 3 years [4-
6]. After the knee, the shoulder is the second most common site 
of  chronic joint pain (63.4%vs. 30.6%) [7]. Shoulder arthroplasty 
accounted for 3%(vs. 96% for hip and knee) of  all inpatient ar-
throplasty procedures performed in 2006. An increase of  2.5x 
(from 19,000 to 47,000) in the number of  shoulder arthroplas-
ties in the United States occurred between the years of  1998 to 
2008, more than 2/3 performed on patients older than age 65 [8]. 
These numbers are significant because trends show between 2012 
and 2050 the US will experience a considerable increase in the 
proportion of  the elderly population. 39.6 million people 65 years 
or older were living in the US in 2009, representing 12.9% of  the 
population or approximately one in every eight Americans. An 
estimate of  43.1 million in 2012, compared to 72.1 million in 2030 
(19% of  the population, more than twice that in 2000), and 83.7 
million projected in 2050 [9]. As these numbers grow, the preva-
lence of  rotator cuff  arthropathy will follow. In combination with 
a larger pool of  patients, the higher level of  activity most older 
individuals enjoy in current times will surely increase the demand 
for surgical intervention to alleviate the debility of  the aforemen-
tioned pathology. This rise in the patient population will increase 
the number of  cases with aberrant anatomy and new tools need 
to be developed to deal with these current and future challenges.
The use of  (RTSA) reverse total shoulder arthroplasties have sky-
rocketed in the past decade, in large part due to the success levels 
and enlarging list of  indications. 96% of  post operative patients 
report no or minimal pain and significant improvements [10]. Sur-
gical indications include certain proximal humerus fractures and 
malunions in elderly patients, pseudoparalysis secondary to irrep-
arable rotator cuff  tear in the setting of  glenohumeral arthritis, 
an incompetent coracoacromial arch (humeral "escape" in subcu-
taneous tissue with hemiarthroplasty), intact bony acromion, low 
functional demand patients, sufficient glenoid bone stock, physi-
ological age >70, working deltoid muscle( intact axillary nerve), 
and patients who are poor candidates for conventional shoulder 
arthroplasty. 
Difficultly arises in the setting of  patients with eccentric glenoid 
wear and compromised bone stock with symptomatic rotator 
cuff  arthropathy in candidates for RTSA. On the basis of  the 
existing data, patients undergoing conventional TSA with 10° to 
15° of  retroversion can be treated with eccentric reaming and use 
of  a glenoid implant, compared to 15° to 25° of  retroversion usu-
ally can be treated with a combination of  slight eccentric reaming, 
bone grafting, or a posterior augmented implant, verse over 25°.
Of  retroversion which is a difficult treatment dilemma. Over the 
past 5-10 years the use of  custom made implants based on CT 
scans has becoming ever popular for the treatment of  patients 
with increasing degrees of  version. This has been done in the 
realm of  conventional TSA on numerous occasions, but only 2 
cases have been found from a computer search in terms of  these 
custom implants used for RTSA. One case advertised on You-
Tube was in the setting of  a 2 stage revision in which a conven-
tional TSA was exchanged for antibiotic spacer, and ultimately a 
custom glenoid implant was inserted for conversion to a RTSA 
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[11]. Another case was in the setting of  a previous complex proxi-
mal humerus fracture with subsequent infections and insertion of  
antibiotic spacers, ultimately resulting in prolonged debility and 
eventual use of  a custom glenoid implant with anterior augmen-
tation for a RTSA [12]. This case report is in the setting of  a 
primary RTSA in the setting of  posterior augmentation for severe 
glenoid retroversion (greater than 25 degrees) with limited bone 
stock. Lower outcome scores are expected for patients undergo-
ing revision TSA secondary to infection and multiple open surgi-
cal procedures on the shoulder [13-15]. Therefore, it is difficult 
to determine the effectiveness of  these implants based on the 
confounding variables of  previous infection and repeat surgical 
intervention.
Case Report
81 year old male with a history of  chronic bilateral shoulder pain 
from rotator cuff  arthroplasty had undergone non operative 
treatment via intra-articular steroid injections and physical thera-
py, which was unsuccessful in alleviating his pain. After failure of  
non operative treatment, the patient decided to undergo operative 
treatment. Proper physical exam, patient history, and advanced 
imaging revealed incompetent supraspinatus tendon, as well as 
severe retroversion of  the glenoid of  the effected shoulder (see 
image 1 and 2). During the preoperative process, the choice of  a 
reverse total shoulder arthroplasty was determined to be the ideal 
construct. The retroversion of  the glenoid was greater than 25 
degrees, and the bone stock was minimal. Choices for eccentric 
reaming for placement of  the base plate of  the glenosphere was 
not the ideal option, and the through of  bone grafting was enter-
tained. Due to minimal bone stock and the technical difficulties 
associated with such a procedure, the option for a custom glenoid 
base plate with a posterior augment was deemed the best option. 
The patient underwent the procedure without any complications, 
and proceed with an uneventful post operative course. At the time 
of  the shoulder grading, the patient claimed the procedure had 
significantly improved his previous symptoms of  discomfort and 
debility, and was very pleased with the outcomes of  the proce-
dure.
Discussion
This case in unique in that the patient received a custom baseplate 
with a posterior augment for a dysplastic glenoid, in someone 
who had never undergone previous surgical intervention to the 
shoulder in question and no confounding variable of  previous 
infection (see image 3 and 4). Also, the previous reports do not 
quantify the outcomes of  the patients in terms of  shoulder scores 
which have been commonly used in the past to determine level of  
function/pain. Such scores have been used in the past to grade 
both TSA and RTSA, which include; DASH score, (Western 
Ontario Osteoarthritis of  the Shoulder [WOOS] index), general 
shoulder rating scales (University of  California at Los Angeles 
[UCLA] shoulder scale, Constant score, and American Shoulder 
and Elbow Surgeons [ASES] evaluation form), general pain scales 
(McGill pain score and visual analogue scale), and a global health 
measure (Short Form-36 [SF-36]) [16]. This case is unique in that 
we have produced a positive patient’s outcome, therefore giving 
insight into treatment success of  patients in a similar setting. 
Image 1. Pre-Operative Imaging of  the Shoulder in Question. Left: Arthrogram, Pre and Post Contrast. Bottom Left: CT 
Reconstruction. Bottom Right: Axial CT Slice Demonstrating Glenoid Retroversion with Dysplasia.
Image 2. Pre-Operative CT Reconstruction of  the Shoulder in Question, used as a Template for the Creation of  the Custom 
Implant.
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The utility of  this device is preservation of  what little bones stock 
patients in this situation already have, and it allows for a much less 
technically demanding procedure to correct for glenoid version. 
Based on the initial success seen with this procedure, this is im-
plant appears to have promising results. We recommend further 
use of  this product and call for increased research into the field 
as more patients receive this implant. With the rising tide of  el-
derly individuals in the population, along with the high incidence 
and debilitating nature of  rotator cuff  arthropathy, these implants 
provide a viable option to treat the complex assortment of  anato-
my which conventional surgical methods are a non-viable option.
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Image 3. Surgical Guide for Implantation of  Custom Implant (Special Thank you to Biomet Corp. of  Warsaw, Indiana).
Image 4. Post Operative Plain Films.
